Metered Dose Inhaler

DEVICE4 trials

Sponsors

Le Bonheur Children's Hospital, GlaxoSmithKline, Polarean, Inc., AstraZeneca

Conditions

AsthmaChronic Obstructive Pulmonary DiseaseHyperinflation

Phase 1

Comparison of Bronchodilator Response From Three Different Aerosol Delivery Methods in Patients With COPD Using Hyperpolarized Xe 129 MRI Ventilation Imaging

Active, not recruitingNCT06271408

Polarean, Inc.Chronic Obstructive Pulmonary Disease

Start: 2024-03-19End: 2026-12-31Target: 6Updated: 2026-10-27

Phase 3

Effectiveness of Fluticasone Furoate/ Umeclidinium/ Vilanterol (FF/UMEC/VI) Using the Connected Inhaler System (CIS) as Compared With Fluticasone Proprionate/ Salmeterol (FP/SAL) Plus Tiotropium (TIO) in Inadequately Controlled Asthma

WithdrawnNCT03376932

GlaxoSmithKlineAsthma

Start: 2019-01-18End: 2021-02-03Updated: 2019-03-25

Phase 4

A Study to Investigate the Effect of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Compared With Placebo MDI on Heart and Lung Function in Participants With Chronic Obstructive Pulmonary Disease (COPD) and Hyperinflation

RecruitingNCT07073950

AstraZenecaChronic Obstructive Pulmonary Disease, Hyperinflation

Start: 2025-11-24End: 2027-05-31Target: 56Updated: 2026-09-18

Unknown Phase

A Randomized Trial Comparing Metered Dose Inhalers and Breath Actuated Nebulizers

CompletedNCT02777125

Le Bonheur Children's HospitalAsthma

Start: 2014-10-31End: 2015-04-30Updated: 2017-08-15